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i(8)(q10) G- banding - Courtesy Melanie Zenger and Claudia 
Haferlach. 
Clinics and pathology 
Disease 
Acute myeloid leukaemia (AML) 
Note: The aberration has also been reported in many 
other neoplastic disorders, most notably T-
prolymphocytic leukaemia (PLL) and acute 
lymphoblastic leukaemia (ALL). In the latter, it often 
occurs as a secondary event to the t(9;22). 
Phenotype / cell stem origin 
Has been reported to occur in all AML FAB types, with 
FAB M2 representing the most common morphology. 
Epidemiology 
A rare non-random event reported in over 50 cases of 
AML (below 0.5% of all cases) and occurs in both 
children and adults. 
Prognosis 
As the aberration is rare and will frequently occur in 
complex karyotypes, whether an independent prognosis 
association can be determined is uncertain. 
Cytogenetics 
Cytogenetics morphological 
In approximately 40% of cases the aberration is 
reported as a chromosome gain. 
Probes 
Use of a centromere 8 probe combined with a C-MYC 
probe will help distinguish between gain of i(8)(q10) 
and simple chromosome 8 gain. 
Additional anomalies 
Seldom occurs as a primary karyotype event. Most 
often found in complex karyotypes and/or arises in a 
sub-clone. The complex karyotypes will frequently 
contain loss of chromosome 5(q) and/or loss of 
chromosome 7(q). 
References 
Rodrigues Pereira Velloso E, Michaux L, Ferrant A, Hernandez 
JM, Meeus P, Dierlamm J, Criel A, Louwagie A, Verhoef G, 
Boogaerts M, Michaux J-L, Bosly A, Mecucci C, Van den 
Berghe H. Deletions of the long arm of chromosome 7 in 
myeloid disorders: loss of band 7q32 implies worst prognosis. 
Br J Haematol 1996;92:574-581. 
Huhta T, Vettenranta K, Heinonen K, Kanerva J, Larramendy 
ML, Mahlamaki E, Saarinen-Pihkala UM, Knuutila S. 
Comparative genomic hybridization and conventional 
cytogenetic analyses in childhood acute myeloid leukemia. 
Leuk Lymphoma 1999;35:311-315. 
Wong KF, Kwong YL. Isochromosome 8q is a Marker of 











Atlas Genet Cytogenet Oncol Haematol. 2007;11(3)  246
Harrison CJ, Yang F, Butler T, Cheung K-L, O'Brien PC, 
Hennessy BJ, Prentice HG, Ferguson-Smith M. Cross-species 
color banding in ten cases of myeloid malignancies with 
complex karyotypes. Genes Chromosomes Cancer 
2001;30:15-24. 
Seppa L, Hengartner H, Leibundgut K, Kuhne T, Niggli FK, 
Betts DR. Loss of i(8)(q10) at relapse in two cases of childhood 
acute myeloid leukaemia. Leuk Lymphoma 2007 (in press). 
This article should be referenced as such: 
Betts D. i(8)(q10) in acute myeloid leukaemia. Atlas Genet 
Cytogenet Oncol Haematol.2007;11(3):245-246.  
 
 
